PLH Genetics
Scientific Review · Rare Diseases

Clarity where genetic uncertainty persists

We provide independent, high-level scientific review of genetic test results in rare diseases, including Variants of Uncertain Significance (VUS)

Secure & Confidential25+ years experience

Understanding Genetic Test Result Uncertainty

Genetic testing is often performed to better understand a medical condition, particularly in rare diseases. In many cases, results clarify the origin and evolution of a condition and may support therapeutic decisions.

However, even when appropriately indicated and technically well performed, reports may identify findings such as a Variant of Uncertain Significance (VUS) that do not clearly explain the clinical situation.

Further high-level scientific reassessment can, in selected cases, provide additional clarity.

This is the purpose of our service: to provide a rigorous and independent scientific review that may contribute to the clinical interpretation of the reported genetic findings.

Read our patient guide to VUS →

Services

What We Do

An independent, case-by-case scientific analysis of complex genetic findings.

Case-by-case analysis

We offer a case-by-case, in-depth scientific analysis of genetic test results presenting complex and inconclusive findings (e.g., Variants of Uncertain Significance).

Multiple scientific perspectives

Each case is analyzed independently from multiple perspectives to establish a rigorous technical and scientific opinion. An online live session with a specialist to address questions or concerns is also available.

Cancer-related tests are not analyzed at this time.
Process

How the Review Is Conducted

A deliberate scientific sequence. Not an algorithmic black box.

The process unfolds in two clear stages, each with its own fee — so you only commit to the full review after the first screening confirms it is worthwhile.

Phase 1 · Initial Screening$55· Decide if a full review is warranted
  1. 01

    Secure and simple upload

    You securely upload the relevant clinical information and genetic test report.

  2. 02

    First evaluation round

    Our team will conduct an initial assessment to determine whether a comprehensive scientific evaluation can be performed.

Phase 2 · Full In-depth Review$359· Only if you choose to continue
  1. 03

    In-depth analysis

    Each case undergoes detailed scientific re-analysis supported by advanced computational tools. Our approach integrates population and molecular genetics, functional genomics data, evolutionary conservation, probability models, clinical information, and structured literature analysis.

  2. 04

    Results downloading and conversation with a specialist

    The results can be downloaded confidentially, and an optional 20-minute conversation with a specialist will be available to address any questions or concerns.

Before You Start

What You Provide

Three inputs are enough to begin the review.

Anonymized
Input #01Document

Genetic test report

Patient identifiers should be removed whenever possible.

OnsetEvolutionCurrent
Input #02Clinical

Brief clinical summary

Describing onset, evolution, and current status.

Input #03Context

Relevant family history

If available.

Pricing

Our Three-Step Scientific Review Process

Transparent, flat pricing in U.S. dollars.

Initial screening

A focused first look at your report.

$55USD

Full in-depth review

The complete scientific reassessment.

$359USD

Optional 20-minute virtual chat with specialist

A live conversation with our scientific team.

$130USD
Deliverables

What You Receive

Two clear outputs — written and, if you choose, spoken.

Report

Written scientific report

Structured written scientific report detailing technical aspects, variant analysis, and independent interpretation.

Optional consultation

Optional private discussion with the Scientific Director.

Scientific Direction

Who Reviews the Data

Professor Paul Laissue

Professor Paul Laissue

Scientific Director

25 years experience

All reviews are conducted by a molecular geneticist with extensive experience in rare diseases.

Each case is reviewed and validated by Professor Paul Laissue, Scientific Director of PLH Genetics, with over 25 years of experience in molecular genetics, functional genomics, and quantitative genetics research.

Disclaimers

Important notice

  • This service provides an independent scientific review of reported genetic findings.
  • It is intended for scientific and educational purposes only and does not constitute medical diagnosis, treatment, genetic counseling, or medical advice.
  • PLH Genetics does not establish a physician-patient relationship.
  • All clinical decisions remain the sole responsibility of the treating healthcare professionals.
FAQ

Common questions

Short answers to what families and physicians ask most.

  • A VUS is a genetic change for which current evidence is insufficient to classify it as benign or disease-causing. A structured scientific reassessment can sometimes resolve that uncertainty.

    Read the full VUS guide

Ready for clarity?